These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17054057)

  • 1. [New agents for solid tumours].
    Raida M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tyrosine kinase inhibitors in tumor therapy--part 1. Molecular and genetic fundamentals].
    Grimm CF; Blum HE; Geissler M
    Dtsch Med Wochenschr; 2005 May; 130(21):1318-22. PubMed ID: 15902620
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyrosine kinases as targets for cancer therapy.
    Krause DS; Van Etten RA
    N Engl J Med; 2005 Jul; 353(2):172-87. PubMed ID: 16014887
    [No Abstract]   [Full Text] [Related]  

  • 4. [Limitations in application of imatinib in hematologic malignancies: are there new principal solutions?].
    Rukavitsyn OA; Pop VP
    Ter Arkh; 2008; 80(7):80-4. PubMed ID: 18763606
    [No Abstract]   [Full Text] [Related]  

  • 5. Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases.
    Chase A; Cross NC
    Clin Sci (Lond); 2006 Oct; 111(4):233-49. PubMed ID: 16961463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Future perspectives. From basic research to the development of new therapies aimed at the inhibition of the different stages of signal transduction: applications in breast cancer].
    Campone M; Kerbrat P; Roché H; Bennouna J; Cuillière JC; Le Mevel B; Fumoleau P
    Bull Cancer; 2003 Oct; 90(10):851-64. PubMed ID: 14706914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tyrosine kinase inhibitors in tumor therapy--part 2. Current position and perspectives].
    Grimm CF; Blum HE; Geissler M
    Dtsch Med Wochenschr; 2005 Jun; 130(23):1438-42. PubMed ID: 15929020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hematologic neoplasms during pregnancy].
    Tartas NE; Foncuberta MC; Avalos JC
    Medicina (B Aires); 2007; 67(6 Pt 2):729-36. PubMed ID: 18422070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
    Heinrich MC; Joensuu H; Demetri GD; Corless CL; Apperley J; Fletcher JA; Soulieres D; Dirnhofer S; Harlow A; Town A; McKinley A; Supple SG; Seymour J; Di Scala L; van Oosterom A; Herrmann R; Nikolova Z; McArthur AG;
    Clin Cancer Res; 2008 May; 14(9):2717-25. PubMed ID: 18451237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
    Albo D; Farrow B; Berger DH
    Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies and hematologic malignancies.
    Smith MR
    Cancer J; 2008; 14(3):184-90. PubMed ID: 18536558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis inhibitors in the treatment of lung cancer.
    Sun S; Schiller JH
    Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecularly target therapy].
    Kiyoi H
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():211-6. PubMed ID: 23133955
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches in metastatic melanoma: biological and molecular targeted therapies.
    Lejeune FJ; Rimoldi D; Speiser D
    Expert Rev Anticancer Ther; 2007 May; 7(5):701-13. PubMed ID: 17492933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENMD-2076 for hematological malignancies.
    How J; Yee K
    Expert Opin Investig Drugs; 2012 May; 21(5):717-32. PubMed ID: 22397360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal-transduction inhibitors in renal cell carcinoma.
    Vogelzang NJ; Sternberg CN
    BJU Int; 2007 May; 99(5 Pt B):1289-95. PubMed ID: 17441926
    [No Abstract]   [Full Text] [Related]  

  • 17. [Future directions of antibody therapy].
    Oguro M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():629-36. PubMed ID: 17474471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Signal transduction by protein tyrosine kinases and antitumor agents].
    Mao YJ; Li HH; Li JF; Shen JS
    Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent topics on leukemia: New molecular targeting therapy].
    Hirai H
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1036-42. PubMed ID: 12866451
    [No Abstract]   [Full Text] [Related]  

  • 20. [New therapeutic approaches in glioblastomas].
    Le Guilloux J; Carpentier AF
    Rev Neurol (Paris); 2008; 164(6-7):554-9. PubMed ID: 18565354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.